Community Pharmacy: an untapped patient data resource by Wright, David & Twigg, Michael
Integrated Pharmacy Research and Practice
Video abstract
Point your SmartPhone at the code above. If you have a 
QR code reader the video abstract will appear. Or use:
http://youtu.be/IPZjCov6Obs
Dovepress
R e v i e w
open access to scientific and medical research
Open Access Full Text Article
© 2016 Wright and Twigg. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/
terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the 
work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).








School of Pharmacy, University of east 
Anglia, Norwich, UK
Correspondence: David John wright 
School of Pharmacy, University of east 
Anglia, earlham Road, Norwich, NR4 7TJ, 
UK 
email d.j.wright@uea.ac.uk
Abstract: As community pharmacy services become more patient centered, they will be 
increasingly reliant on access to good quality patient information. This review describes how 
the information that is currently available in community pharmacies can be used to enhance 
service delivery and patient care. With integration of community pharmacy and medical practice 
records on the horizon, the opportunities this will provide are also considered. The community 
pharmacy held patient medication record, which is the central information repository and has 
been used to identify non-adherence, prompts the pharmacist to clinically review prescriptions, 
identify patients for additional services, and identify those patients at greater risk of adverse 
drug events. While active recording of patient consultations for treatment over the counter may 
improve the quality of consultations and information held, the lost benefits of anonymity afforded 
by community pharmacies need to be considered. Recording of pharmacy staff activities enables 
the workload to be monitored, remuneration to be justified, critical incidents to be learned from, 
but is not routine practice. Centralization of records between community pharmacies enables 
practices to be compared and consistent problems to be identified. By integrating pharmacy 
and medical practice records, patient behavior with respect to medicines can be more closely 
monitored and should prevent duplication of effort. When using patient information stored in a 
community pharmacy, it is, however, important to consider the reason why the information was 
recorded in the first instance and whether it is appropriate to use it for a different purpose without 
additional patient consent. Currently, community pharmacies have access to large amounts of 
information, which, if stored and used appropriately, can significantly enhance the quality of 
provided services and patient care. Integrating the records increases opportunities to enhance 
patient care yet further. While community pharmacies have significant amounts of information 
available to them, this is frequently untapped.
Keywords: information, patient data, patient medication records, community pharmacy, patient 
services, primary care
Introduction
A recent vision for community pharmacy developed by 14 experts from eight different 
countries was of increased provision of patient-centered care facilitated by the develop-
ment of new technology, including information technology-based documentation and 
access to shared patient data.1 However, it could be argued that even without this new 
technology, the community pharmacy already has significant amounts of data which 
if obtained, stored, and used correctly could assist in the provision of enhanced patient 
care. This review provides an overview of the different ways in which community 
pharmacy data have been used to date and could be used in the future. In reviewing 





the literature related to this subject, the reader will see how 
information, which is currently held, is in itself an untapped 
resource.
Patient medication records
Patient medication records held in community pharmacies, 
which store patient information and the history of medicine 
supplies made from the pharmacy are now ubiquitous in 
western health. Such systems when used in their most basic 
format enable the pharmacist to identify interactions when 
new medicines are prescribed, check the appropriateness of 
over-the-counter medicine requests, and are used to facili-
tate the temporary supply of medicines, which the patient 
requires when they have been unable to access them in a 
timely manner from their general practitioner (GP). A more 
recent use of the basic patient medication record has been 
to identify the newly prescribed2,3 and regular medicines4 to 
enable pharmacists to provide advice to patients as a remuner-
ated service. All of these activities rely on either the patient 
regularly using the same pharmacy or pharmacies being 
linked up to enable patients (and data) to transfer between 
them. With such large numbers of medicine-related errors 
occurring when patients transfer into hospital, community 
pharmacy held patient medication records have also been 
successfully used to ensure that medicines are correctly 
supplied and administered on admission to hospital as part 
of the medicines reconciliation process.5
Researchers in Australia have recently used patient 
medication records to insert a prompt for the community 
pharmacist to question the appropriateness of a prescription 
for a high-dose proton pump inhibitor. This simple decision 
support aid, that is relatively easy to include within patient 
medication recording systems, resulted in reductions in 
prescribing cost and improvements in prescribing quality.6 
The routine collection of medicines from the community 
pharmacy provides numerous opportunities to review pre-
scribing and confirm its appropriateness through interaction 
with the patient. The information held within the pharmacy 
is central to this and provides the opportunity and support 
for brief interventions to optimize prescribing, which may be 
worthy of remuneration. However, it is important for patient 
medication records to be accurate and well maintained as this 
enables new medicines to be correctly identified and prevents 
unnecessary future interventions if the appropriateness of 
therapy has previously been questioned and confirmed.
While most pharmacy systems will enable large amounts 
of patient-specific data to be stored, the pharmacist frequently 
does not request or record information beyond that required 
for routine dispensing, eg, allergies or medical conditions.7 
Possible reasons for this include a lack of time to collect and 
record the data and patients requiring an efficient service, 
which is not delayed by answering numerous additional 
questions. Therefore, the question is whether the benefits 
obtained from maintaining more complex records justify 
the extra time taken to complete them. Routinely recording 
allergies and patient’s medical conditions would enable the 
appropriateness of patients for certain services to be quickly 
determined and would remove the need for guessing the 
patient’s conditions based on their medicines. At the very 
least, community pharmacists can use their patient medica-
tion records to record approaches for additional services 
and patient willingness to participate to prevent others from 
duplicating the offer at a later date.
Another use of the patient medication record could be to 
identify patients who are not taking their medicines as pre-
scribed. Non-adherence to prescribed therapy is believed to 
represent a significant cost to the society due to both wastage 
of medicines and reduced patient outcomes.8 Unfortunately, 
patient adherence is prone to reactivity bias, and the fact 
that as soon as it is measured and the patient is aware of this 
observation, it is likely to change. Consequently, effective 
approaches to identify non-adherence, which do not affect 
patient behavior, are required. Researchers have shown that 
it is possible to identify potential non-adherence through 
review of community pharmacy patient medication records 
and assuming that noncollection of regular prescriptions is 
related to nonadherence,9 thus providing an opportunity for 
pharmacists to intervene and support the patients with their 
medicines to be taken in a timely manner.
The routine recording of prescription supply can, there-
fore, be used to increase the sensitivity and specificity of 
screening services and, therefore, cost-effectiveness of the 
process. The receipt of regular prescriptions for the treatment 
of hypertension has been used to identify patients at risk of 
more specific conditions such as hypercholesterolemia10 and 
has demonstrated potential in the case of identifying patients 
at risk of diabetes.11
In addition to the provision of relatively brief interven-
tions for the purposes of improving public health, the man-
agement of chronic illness is seen as central to the future 
of community pharmacy. Consequently, patient medication 
records have been used to identify patients who may benefit 
from chronic disease support or interventions to optimize 
medication. In one study designed to improve management 
of chronic obstructive pulmonary disease, routine supply 
of inhaler therapy was used to identify potentially suitable 





patients thereby focusing recruitment,12 while in another, 
the regular receipt of four or more medicines was used as a 
proxy for risk from adverse drug events.13
However, in terms of appropriately identifying and 
supporting patients, the main information source that is 
frequently untapped within the pharmacy are the patients 
themselves. They carry a wealth of information regarding 
their medicine-taking behaviors, beliefs about medicines, 
previous medication, and social history. While such infor-
mation is obtained in all other health care settings, this is 
not routine practice within the community pharmacy. How-
ever, increasingly, short questionnaires are being used to 
enable risk identification for public health intervention,14 to 
inform the pharmacist about patient’s medicines taking and 
tailor their intervention accordingly,12 and, when combined 
with the patient medication record, to determine the need for 
drug-related intervention.15
Over-the-counter sales
One area of “information” that is currently available within 
community pharmacies but not routinely recorded as patient-
related data is individual purchases of medicines over the 
counter. The regular purchase of medicines for the treatment 
of cough has successfully been used to identify patients who 
may be at risk of chronic obstructive pulmonary disease.16 
Similar approaches could theoretically be used for screening 
conditions such as celiac disease when patients purchase 
medicines for the treatment of diarrhea, or diabetes with 
frequent purchases of anti-fungal treatments.
It has been suggested that recording patient purchases 
would not only deter abuse commonly seen with over-the-
counter medicines17 but also enable its identification.17,18 By 
standardizing the questions asked, which should occur as a 
result of recording the consultation, drug-related problems 
would be more consistently identified19 and diagnosis would 
be improved.20
While such a change in practice may improve patient 
care, it would affect the cost of service delivery and possible 
patient satisfaction if they want to just make a simple pur-
chase. Furthermore, the anonymity afforded by community 
pharmacies and used to reduce barriers to the purchase of 
emergency contraception and chlamydia screening would 
be lost. The centralization of patient records and ability for 
patients to provide access and make records at their behest 
may, however, address this, as patients can decide when they 
want medicine purchases to be recorded and checked by 
the pharmacist against their current records. Requests for 
medicines liable to abuse where the patient does not request 
inclusion into their patient record may prompt the pharmacist 
or pharmacy staff to consider whether anonymity is being 
used to inappropriately procure such medicines.
General community pharmacy 
information
While information technology systems are central to the 
provision of medicine-based services,21,22 recording the 
drug-related problems and actions to address them is also 
important as it enables the pharmacist to plan their activi-
ties and monitor the outcomes.23 The routine recording of 
pharmacist interventions also enables frequently occurring 
prescription-related errors to be identified and fed back to 
the prescriber to improve patient care.24
To describe community pharmacist activities with respect 
to certain conditions, survey methods and interviews are fre-
quently used.25–27 However, survey methods rely on memory 
recall and are prone to social desirability bias. A more accu-
rate picture would be obtained if community pharmacists 
accurately recorded their drug-related activities contempora-
neously. Not only would this information enable differences 
in practice between pharmacists and community pharmacies 
to be identified and quantified, it would also provide justifica-
tion to service purchasers for the remuneration received for 
services that are currently nontangible. Such a system has 
been introduced and tested in Australia and shown to improve 
the understanding of exactly what pharmacists do.28 Simi-
larly, a national database to record community pharmacist 
interventions has been set up in the UK to enable community 
pharmacists to obtain reimbursement for services and update 
medical practice records automatically with the information 
regarding community pharmacist activities.29 This database 
has been successfully used for the evaluation of new com-
munity pharmacy-based services.12,13
Workload sampling is an approach where additional data 
regarding pharmacist and staff activities has been used to 
review and improve workflow, and hence inform the delivery of 
patient services.30–32 However, data regarding practice activities 
are only useful when the data can be used to compare between 
pharmacies to enable the differences to be identified.
Routine recording of near-miss events or errors within 
the pharmacy can also be used by the pharmacy to improve 
patient safety through the use of critical incident analysis.33 
While medication errors remain illegal in some countries,34 
this information is frequently not recorded. Due to the limited 
number of serious errors that occur and incomplete recording 
of near-miss events, this information is more useful when it 
is stored in a centralized database and consequently patterns 





emerge, which enable identification of strategies to prevent 
future occurrence.33
Similarly, centralization of prescription reclaim informa-
tion, which is naturally occurring as a result of electronic 
prescribing,35 enables the costs of medicines from different 
suppliers to be compared. Using such an approach, research-
ers in the USA have shown that medicines supplied from 
Internet pharmacies are less expensive than that from retail 
pharmacies.36 Centralized records have also enabled the 
identification of falsified prescriptions.26
Integration of patient records
Integration of patient records can and is occurring at vari-
ous levels. First, and perhaps most simply, is that between 
community pharmacies who use the same dispensary-based 
software. Linking the community pharmacy records enables 
patient’s medicine-related behavior to be more accurately 
recorded as many pharmacies will have incomplete records 
where patients have chosen another community pharmacy 
for receipt of a supply of medicines. Such an approach is 
believed to provide rich medicines utilization data, which 
can be used for research purposes.37 Geographic Information 
Systems technology that is used to create maps of patient 
activity has been used to analyze linked community pharmacy 
information and been able to identify variation in local use 
of prescription medicines, at both individual and population 
levels.38 The capture of medication-related behavior enables 
questions to be asked regarding variation in service provision 
at a population level and to obtain more accurate pictures of 
individual patient behavior. This additional information can 
then be used to tailor interventions both to the local popula-
tions and individual patients.
Linking the pharmacy and GP records, which is tech-
nologically and professionally more problematic,39 provides 
additional opportunities for medicines utilization research. 
GP records state what was prescribed, provided it was 
entered electronically, while pharmacist records state what 
was actually collected. Therefore, linking the community 
pharmacy and GP databases enables a more accurate and 
complete picture of drug utilization to be obtained.40 The 
prescriber will have a more accurate picture of patient’s 
medicine-taking behavior available to them when authoriz-
ing new prescriptions and considering increasing dosages 
in light of apparent therapeutic failure, which may actually 
be non-adherence. The pharmacist will additionally be able 
to confirm whether prescriptions have been authorized and 
at what dose and use this information to support patients 
who present without their medicines requiring additional 
supplies in an emergency.
While the integration of such records between different 
health care professionals should prevent the patient from 
being asked duplicate questions and provide more informa-
tion to the pharmacist when deciding whether to offer a new 
service to a patient, it may also increase pressure on the 
pharmacist to ensure that records are complete and up to date. 
Qualitative research to determine community pharmacist 
views on the integration of records between themselves and 
GPs identified concerns regarding exactly what they would 
not be expected to record with a request for some flexibility 
within this39 as their entries would be available for other 
health care professionals to view.
Finally, with the increasing use of point-of-care testing 
within community pharmacies,10,41 the risk of duplicated effort 
by community pharmacists and GPs, and consequently, an 
ability to relay test results to the patient’s primary care physi-
cian also becomes more important. This avoidance of dupli-
cation has also been identified with regard to medicine use 
reviews in the UK, with GPs stating that as a reason for their 
reluctance to engage with pharmacy-provided services.42,43
Big Brother
As databases become more integrated and powerful, the abil-
ity to monitor patient behavior is increased. If this progress 
is not carefully managed, we potentially move closer to Big 
Brother seen in George Orwell’s 1984, particularly when 
the services we want to provide are those that the society 
has decided are for the greater good but do not align with 
individual lifestyle choices.
While supermarkets already monitor our purchases and 
provide coupons and offers that are individualized to our 
preferences, they do this through loyalty cards, which we 
have signed up for, to know that information would be used 
in this manner. Similarly, while the software used in medical 
practices, where GP records are held, is frequently designed 
to monitor the frequency of our prescription requests and can 
be used by GPs when discussing medicines, patients have 
usually registered with the medical practice to allow personal 
information to be stored and monitored and do this on the 
assumption that all information is being used for their benefit. 
Occasionally, medical practices will approach patients on 
behalf of researchers to determine whether they would like to 
be involved in a study related to their demographics or medi-
cal condition, but do this in the knowledge that the research 
may be of benefit; the research team have not had prior access 





to patients’ information, and they have to provide consent to 
participate before any information is released to them.
Community pharmacists obtain patient information 
through the supply of medicines either by prescription or over 
the counter. In the UK at least, patients are not required to 
register with their community pharmacy or provide consent 
for their prescription information to be stored. The law allows 
this information to be stored without consent provided that 
it is used for limited, specifically stated purposes.44 Conse-
quently, patients visiting community pharmacies may not 
be so comfortable if they knew that community pharmacists 
were using such information to determine which additional 
remunerated services to provide to them or that we were 
actively sharing information with other health care profes-
sionals to obtain a more accurate picture of their behavior.
Therefore, whenever we choose to use patient information 
held within community pharmacies to extend or enhance the 
range of services offered, it is important that we consider the 
patient’s perspective and that we obtain consent to use the 
information for other purposes where appropriate.
Conclusion
Information stored within community pharmacy patient 
medication records routinely enhances patient care through 
the ability to identify interactions between new medicines and 
existing therapy and by supporting the provision of medicines 
to patients who have failed to obtain their medicines in a 
timely manner. However, it provides a multitude of oppor-
tunities to further enhance patient care, many of which are 
currently untapped either due to a lack of resources to fund 
services based upon them or due to a lack of awareness of 
how the information could be more usefully used.
Information held within patient medication records can 
be used to identify potential patient non-adherence, identify 
patients who may benefit from public health interventions, 
and facilitate the identification of patients for chronic illness 
management. It can be used to prompt for medication review 
when high-risk medicines or dosages are prescribed and be 
used for routine monitoring of patients. The information 
held within patient medication records can also be used to 
support the medicines reconciliation process when patients 
transfer into hospital.
The usefulness of such information is enhanced further 
when records between pharmacies are combined, and then, 
again when these are linked to medical practices. However, 
many new services can be provided using the information 
available in individual pharmacies that have a regular patient 
base. However, the quality of information held within patient 
medication records will affect the efficiency of new service 
provision as the more accurate and complete it is the more 
focused approaches to patients can be and less unnecessary 
duplication of effort should occur.
Information in community pharmacies regarding near-
miss and actual errors, if recorded and collated, can be used 
to improve local practices and patient safety. Similarly, 
actively recording pharmacist and staff activities can be used 
to describe working practices in order to enable their review 
and optimization of service delivery. Recording all medicine-
related activities is helpful to enable feedback to prescribers 
to prevent similar errors and demonstrate exactly what phar-
macists do and, therefore, justify their professional role.
The purchase of medicines over the counter is currently 
an area where there is a lot of potentially useful information 
that could be collated either to identify patients who may 
benefit from screening or public health interventions or to 
identify abuse, which requires greater support. Empowering 
the patients to decide when such purchases can be recorded 
should increase the wealth of information available regarding 
patient self-medication and enable those patients choosing 
not to record information to be identified.
The patient is a source of information that routinely 
enters a community pharmacy, and this has been tapped by 
the use of short questionnaires to enable risk assessment to 
be performed and inform interventions to enable them to be 
tailored to the individual patient.
Integration of patient records between different practitio-
ners will enable a more accurate picture of medicines utili-
zation and cost to be obtained, thus providing opportunities 
for tailoring services both geographically and individually. 
While linking of records increases the quality of information 
available, its eventual effectiveness will depend on whether 
individuals have time and sufficient incentives to access and 
use the collated data.
When considering using patient information for purposes 
for which it was not intended, ie, using prescription supply 
information to identify patients possibly in need of a public 
health intervention, we need, however, to think carefully about 
the appropriateness of this, not only within the confines of 
local legislative frameworks for data management, but also 
from the perspective of the patient who may not be aware that 
their data are being used in this manner. Information held 
within community pharmacies is untapped as it currently 
stands; however, tapping it may, in certain circumstances, 
require a review of how the data were collected in the first 





place and what the patient was told the information would 
be used for.
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